WBAP – Learning From Legends (3rd July 2021)

10 replies on “WBAP – Learning From Legends (3rd July 2021)”

Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.

Many patients are presenting with multi-organ involvement without fever. what might be the diagnosis?

Post covid K.D Immunoglobulin test which: Total;IgG;spilke protein from where?anylevel parameter?

What might be the incidence of MIS-C in 3rd wave as already the seroprevalence of pediatric covid is >50% in India?

Sir
Thanks for an elaborate talk
– Which group would you recommend upfront intensification in KD; as the evidence for benefit in terms of reduction in CAA in a high-risk group is still not robust.
-Thoughts on upfront use of steroids as primary therapy in KD in place of IVIG, particularly for resource-poor settings.

Leave a Reply

Your email address will not be published.